Uncategorized

Amy Schulman is the second veteran of the pharmaceutical industry that Elevance has added to its board this year.

Hammons has served as interim CEO of the hospital operator since October. Also on Wednesday, Jason Johnson, previously CHS’ chief accounting officer, was appointed CFO.

The proposed cybersecurity rule, released during the waning days of the Biden administration, would add “substantial new financial burdens” on providers, the groups wrote to the HHS.

The plan to extend the more generous financial assistance for three years is expected to go up for a vote in the Senate Thursday, alongside a Republican alternative that would replace the subsidies. 

The FDA is becoming deeply compromised and increasingly at risk of being permanently transformed in ways contrary to its mission, history and culture.

Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial.

In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.

Pfizer is in the midst of an aggressive, multi-year cost-cutting effort, which so far has left nearly 2,000 people jobless.

While overall survival remains immature, results so far show a clear trend in favor of Roche’s giredestrant.

Also on Thursday, Zealand held its Capital Markets Day in London, outlining the strategy for its weight management franchise in the near-term, including launching five products by 2030.